0000947871-24-000751.txt : 20240912
0000947871-24-000751.hdr.sgml : 20240912
20240912165636
ACCESSION NUMBER: 0000947871-24-000751
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240912
DATE AS OF CHANGE: 20240912
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd.
CENTRAL INDEX KEY: 0001534248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813676773
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38807
FILM NUMBER: 241295561
BUSINESS ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
BUSINESS PHONE: 972-77-331-0156
MAIL ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
FORMER COMPANY:
FORMER CONFORMED NAME: Anchiano Therapeutics Ltd.
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: BioCancell Ltd.
DATE OF NAME CHANGE: 20111104
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: OrbiMed Israel GP Ltd.
CENTRAL INDEX KEY: 0001569590
ORGANIZATION NAME:
IRS NUMBER: 980697983
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR
CITY: HERZLIYA
STATE: L3
ZIP: 46766
BUSINESS PHONE: 212-739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022-4629
144
1
primary_doc.xml
144
0001569590
XXXXXXXX
LIVE
0001534248
Chemomab Therapeutics Ltd.
001-38807
Kiryat Atidim
Building 7
Tel Aviv
L3
6158002
972-77-331-0156
OrbiMed Israel Partners Limited Partnership
Owner
American Depositary Shares
Morgan Stanley
1585 Broadway
New York
NY
10036
500000
1015000.00
18508057
09/12/2024
Nasdaq Stock Market
American Depositary Shares
03/16/2021
Merger
Issuer
N
500000
03/16/2021
N/A
Y
OrbiMed Israel BioFund GP Limited Partnership is the general partner of OrbiMed Israel Partners Limited Partnership. OrbiMed Israel GP Ltd. is the general partner of OrbiMed Israel BioFund GP Limited Partnership.
09/12/2024
/s/ Douglas Coon, CCO, OrbiMed Israel GP Ltd., general partner of the general partner of OrbiMed Israel Partners Limited Partnership